• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用人类血清鉴定的P3H4-1伯基特淋巴瘤细胞可溶性补体结合抗原的稳定性和解离

Stability and dissociation of P3H4-1 Burkitt's lymphoma cell soluble complement-fixing antigen identified with human serum.

作者信息

Weliky N, Leaman D H, Kallman B J

出版信息

Cancer Res. 1975 Jun;35(6):1580-5.

PMID:236823
Abstract

The soluble complement-fixing antigen of the P3HR-1 Burkitt's lymphoma cell line, identified with human serum containing antibody against Epstein-Barr virus viral capsid antigen, loses activity under a variety of conditions. The major characteristic reported here is retention of activity on exposure to specific physical or chemical conditions followed by loss of activity after subsequent neutral dialysis. Antigen of untreated cell lysates, which retains activity after dialysis against large volumes of neutral buffers or 0.14 M NaCl, will lose activity if the lysate is first heated to 56 degrees or if the lysate is exposed to acid perchlorate, and the resulting precipitate and supernatant are redialyzed separately to neutral pH. The P3HR-1 soluble complement-fixing antigen appears to be an aggregate including a labile, dissociable component.

摘要

用含抗爱泼斯坦 - 巴尔病毒衣壳抗原抗体的人血清鉴定出的P3HR - 1伯基特淋巴瘤细胞系的可溶性补体结合抗原,在多种条件下会失去活性。此处报道的主要特征是,在暴露于特定物理或化学条件下时抗原保留活性,而在随后的中性透析后失去活性。未经处理的细胞裂解物的抗原,在针对大量中性缓冲液或0.14M NaCl透析后仍保留活性,但如果裂解物先加热至56℃,或者裂解物暴露于高氯酸,然后将所得沉淀和上清液分别重新透析至中性pH,则会失去活性。P3HR - 1可溶性补体结合抗原似乎是一种聚集体,包括一个不稳定、可解离的成分。

相似文献

1
Stability and dissociation of P3H4-1 Burkitt's lymphoma cell soluble complement-fixing antigen identified with human serum.用人类血清鉴定的P3H4-1伯基特淋巴瘤细胞可溶性补体结合抗原的稳定性和解离
Cancer Res. 1975 Jun;35(6):1580-5.
2
Differences between soluble complement-fixing antigens derived from P3HR-1, RAJI, and Hk-Ly-28 cell lines.源自P3HR-1、RAJI和Hk-Ly-28细胞系的可溶性补体结合抗原之间的差异。
J Natl Cancer Inst. 1975 Mar;54(3):593-6.
3
Purification of soluble complement-fixing antigens from two Burkitt's lymphoma cell lines. Conditions affecting the stability and recovery of antigens and antibodies.从两种伯基特淋巴瘤细胞系中纯化可溶性补体结合抗原。影响抗原和抗体稳定性及回收率的条件。
Immunology. 1975 Oct;29(4):779-90.
4
New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.检测非生产性淋巴母细胞系中爱泼斯坦-巴尔病毒关联的新方法。
Cancer Res. 1983 Nov;43(11):5064-7.
5
Association of Epstein-Barr virus and American Burkitt's lymphoma.爱泼斯坦-巴尔病毒与美国伯基特淋巴瘤的关联。
IARC Sci Publ (1971). 1975(11 Pt 2):37-43.
6
Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).一种源自髓系白血病的人类细胞系(K562)与一种人类伯基特淋巴瘤细胞系(P3HR - 1)的杂交。
J Natl Cancer Inst. 1980 Apr;64(4):725-38.
7
Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).携带表面免疫球蛋白A且爱泼斯坦-巴尔病毒核抗原(EBNA)呈阴性的伯基特淋巴瘤细胞系。
Jpn J Exp Med. 1980 Dec;50(6):423-34.
8
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.淋巴瘤衍生细胞系的特征:爱泼斯坦-巴尔病毒核抗原阳性和阴性细胞系的比较。II. 表面标志物
J Natl Cancer Inst. 1980 Mar;64(3):477-83.
9
The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.伯基特淋巴瘤免疫学发现的临床意义。(爱泼斯坦-巴尔病毒相关抗体/卡介苗治疗)
Hamatol Bluttransfus. 1974;14:129-32.
10
B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.B淋巴细胞母细胞抗原(BB-1)表达于爱泼斯坦-巴尔病毒激活的B淋巴细胞母细胞、B淋巴母细胞样细胞系和伯基特淋巴瘤细胞上。
J Immunol. 1982 Feb;128(2):823-7.

引用本文的文献

1
Purification of soluble complement-fixing antigens from two Burkitt's lymphoma cell lines. Conditions affecting the stability and recovery of antigens and antibodies.从两种伯基特淋巴瘤细胞系中纯化可溶性补体结合抗原。影响抗原和抗体稳定性及回收率的条件。
Immunology. 1975 Oct;29(4):779-90.